Professor Christian Becker: key facts
- Kind of voice
- Academic
- Role
- Co-Director of the Endometriosis CaRe Centre in Oxford, co-lead on the study and joint senior co-author
- Quoted on
- Women's health & gynaecology
- Press citations held
- 2
- Most recently quoted
- 30 Sept 2026
“an important step toward expanding therapeutic options for women living with endometriosis”
What Professor Christian Becker has said
“Novel, non-invasive diagnostic tests for endometriosis are a global research priority. The diagnostic challenge of endometriosis, which presents with varied and non-specific symptoms, is exacerbated by an absence of clinically validated biomarkers and the limitations of currently available imaging techniques. If these Phase II results are reproduced in the Phase 3 studies, maraciclatide has the potential to be an extremely valuable tool, as it could both reduce diagnostic delays and provide a validated endpoint for the development of new therapeutics.”
Co-Director of the Endometriosis CaRe Centre in Oxford, co-lead on the study and joint senior co-author · Women's health & gynaecology · 30 Sept 2026 · Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool ↗
Where Professor Christian Becker has been quoted
- Gesynta’s endometriosis candidate enters phase 2emjreviews.com · 30 Sept 2026
- Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Toolprnewswire.com · 30 Sept 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.